ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,836.22
0.16%
US Tech 100
20,372.80
0.74%
Dow Jones
42,297.12
0.86%
Brent Oil
80.365
0.11%
Bitcoin
97,039.10
2.68%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Onward Medical NV (ONWD) Quote

Onward Medical NV

Onward Medical NV (ONWD)

Onward Opportunities Limited
6.34
0.04
( 0.63% )
Updated: 04:31:04
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
6.34
Bid
6.30
Ask
6.34
Volume
62,116
6.16 Day's Range 6.46
1.85 52 Week Range 6.74
Market Cap
219.547M
Previous Close
6.30
Open
6.32
Last Trade
2
@
6.34
Last Trade Time
04:31:04
Financial Volume
-
VWAP
-
Average Volume (3m)
127,788
Shares Outstanding
34,628,832
Dividend Yield
-
PE Ratio
-5.97
Earnings Per Share (EPS)
-1.04
Revenue
532k
Net Profit
-36.18M

About Onward Medical NV

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.onwd.com
Headquarters
Eindhoven, North Brabant, Nld
Founded
-
Onward Medical NV is listed in the Medical Laboratories sector of the Euronext with ticker ONWD. The last closing price for Onward Medical NV was 6.30 €. Over the last year, Onward Medical NV shares have traded in a share price range of 1.85 € to 6.74 €.

Onward Medical NV currently has 34,628,832 shares outstanding. The market capitalization of Onward Medical NV is 218.16 € million. Onward Medical NV has a price to earnings ratio (PE ratio) of -5.97.

Ask ADVFN Intelligence (AI)

ONWD Latest News

More News

ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference CEO Dave Marver to Provide Company Update Wednesday, January 15, 2025EINDHOVEN, the Netherlands, Jan. 13, 2025...

January 13 2025
UK Regulatory

ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

EINDHOVEN, the Netherlands, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to...

January 13 2025
GlobeNewswire Inc.

ONWARD Medical Announces First Commercial Sales of ARC-EX System

UW Medicine and Next Steps Chicago both purchased systems in late December 2024 ARC-EX is the first and only FDA approved technology indicated to improve hand strength and sensation in people...

January 09 2025
GlobeNewswire Inc.

ONWARD Medical Announces First Commercial Sales of ARC-EX System

ONWARD Medical Announces First Commercial Sales of ARC-EX System UW Medicine and Next Steps Chicago both purchased systems in late December 2024 ARC-EX is the first and only FDA approved...

January 09 2025
UK Regulatory

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) ARC-EX System is the first and only FDA approved technology...

December 19 2024
GlobeNewswire Inc.

ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière destiné aux personnes atteintes de lésion chronique de

ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière...

December 19 2024
UK Regulatory

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury THIS PRESS...

December 19 2024
UK Regulatory

ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability

ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability EcoVadis silver medal recognizes Company's environmental and social impact Demonstrates ongoing commitment to...

December 12 2024
UK Regulatory

ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability

EcoVadis silver medal recognizes Company's environmental and social impact Demonstrates ongoing commitment to integrating sustainable business practices EINDHOVEN, the Netherlands, Dec. 12, 2024...

December 12 2024
GlobeNewswire Inc.

ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights

ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company’s top investor Signed exclusive...

November 26 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.8615.69343065695.486.745.42839396.12161704DE
41.5231.53526970954.826.744.622012535.57294415DE
120.243.934426229516.16.744.511277885.20085418DE
260.9617.8438661715.386.744.51749495.22911893DE
523.29107.8688524593.056.741.85844695.10666805DE
156-2.06-24.52380952388.412.281.85336325.16553302DE
260-6.68-51.305683563713.0213.281.85326015.48311952DE

ONWD - Frequently Asked Questions (FAQ)

What is the current Onward Medical NV share price?
The current share price of Onward Medical NV is 6.34 €
How many Onward Medical NV shares are in issue?
Onward Medical NV has 34,628,832 shares in issue
What is the market cap of Onward Medical NV?
The market capitalisation of Onward Medical NV is EUR 218.16M
What is the 1 year trading range for Onward Medical NV share price?
Onward Medical NV has traded in the range of 1.85 € to 6.74 € during the past year
What is the PE ratio of Onward Medical NV?
The price to earnings ratio of Onward Medical NV is -5.97
What is the cash to sales ratio of Onward Medical NV?
The cash to sales ratio of Onward Medical NV is 405.19
What is the reporting currency for Onward Medical NV?
Onward Medical NV reports financial results in EUR
What is the latest annual turnover for Onward Medical NV?
The latest annual turnover of Onward Medical NV is EUR 532k
What is the latest annual profit for Onward Medical NV?
The latest annual profit of Onward Medical NV is EUR -36.18M
What is the registered address of Onward Medical NV?
The registered address for Onward Medical NV is HIGH TECH CAMPUS 32, EINDHOVEN, NORTH BRABANT, 5656 AE
What is the Onward Medical NV website address?
The website address for Onward Medical NV is www.onwd.com
Which industry sector does Onward Medical NV operate in?
Onward Medical NV operates in the MEDICAL LABORATORIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALBPSBiophytis
0.43 €
(62.39%)
397.81k
BNBSTonner Drones
0.002 €
(33.33%)
594.23k
ALBOOBOOSTHEAT
0.116 €
(28.89%)
911
ALCHIAlchimie
0.417 €
(17.46%)
136.11k
SEQUASequana medical NV
2.98 €
(15.95%)
101.59k
ALCYBCybergun
0.0001 €
(-50.00%)
16.32M
NICBSNicox SA
0.0175 €
(-27.08%)
400
ALUCILucibel
0.1272 €
(-9.92%)
9.03k
ALAGOEPango SA
0.1554 €
(-8.91%)
1.11M
ALENTEntreparticuliersCom
0.43 €
(-8.51%)
693
ATOAtos SE
0.0022 €
(0.00%)
471.72M
BCPBanco Comercial Portugues SA
0.4824 €
(0.46%)
18.09M
ALCYBCybergun
0.0001 €
(-50.00%)
16.32M
ALVERVergnet
0.0016 €
(-5.88%)
12.07M
ALCBXCibox Interactive
0.042 €
(1.45%)
3.32M

Discussion

View Full Feed
Golden Cross Golden Cross 6 minutes ago
$ILLR Many Reasons To Like Triller Now!

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal court just upheld
ILLR
Golden Cross Golden Cross 7 minutes ago
💎 $ILLR Many Reasons To Like Triller Now⬇️

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal cour
ILLR
kspar1 kspar1 9 minutes ago
Wow! I had no idea the JPM conference in San Francisco is as energetic as this link reads, including the partnership announcements. Will be fun to see how Anavex is positioned. The conference supposed to generate $92M for the city.
https://www.fiercebiotech.com/biotech/jpm25-day-1-fierce-bio
JPM
Frankestin Frankestin 10 minutes ago
Truist Securities raises PT to $180 from $150 😮
The next two weeks will be eventful
AXS-07, a candidate for the acute treatment of migraines, with expectations for regulatory approval
NDA for AXS-14 for fibromyalgia... maybe yes or maybe no
AXSM
Number sleven Number sleven 14 minutes ago
https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amarin-pharma-inc/?page=2
Sleven,
AMRN
price_and_volume price_and_volume 17 minutes ago
"Right news" gonna get $175-350MM market cap? LOL!

Omg what a maroon.
VXIT
The Danish Dude The Danish Dude 17 minutes ago
Nice and interesting analysis, but completely irrelevant >!

I fed ChatGPT the following five comments regarding this analysis and it disagrees with you.

I saw these comments regarding how MHRA approves or rejects medecines at mhra meetings

1
NWBO
lakers17 lakers17 19 minutes ago
MTC back to $96,000 after hitting $89, 200s yesterday. Cryptos I added to in the last couple of days were BOBO, PAI, OTTO and CLUSTR. RING AI looking better. Boom or bust for me.
MTC
Golden Cross Golden Cross 22 minutes ago
Loading Zone Here! $ASII
ASII
Hi_Lo Hi_Lo 31 minutes ago
Where is the CSE press release filing?

TWOH has been halted for more than a week now and the CSE press release is still missing.

Could the run up before the halt be the problem?

Could some people have been tipped off before the run up?

Coul
TWOH
SkeBallLarry SkeBallLarry 39 minutes ago
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/473323273_992397186268896_4170433101098362110_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=833d8c&_nc_ohc=UebR9WKXEXsQ7kNvgELlMGV&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AvB9U-Cb1bfWGguzkXzMzar&oh=00_AYDqG-tA0ScuUz90hSjz11X1LQL5aezyuhOfdBXmp9pGuQ&oe=678C04
Dodger1 Dodger1 40 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652942 I Miss Real
AABB
jondoeuk jondoeuk 43 minutes ago
NEUK201-00* is being tested in advanced/metastatic solid tumours at a single site.

https://i.postimg.cc/fyWcxcwj/download.png

* It could be an iNK with just a high-affinity non-cleavable CD16(a) receptor, but this comes from a Chinese site that has under
HPQ
marcis marcis 45 minutes ago
I was just thinking the same thing

Go bother those serial OTC stock hijackers
( we know them all well ) that’s been doing LOI mergers, asset ( no asset ) transfers for years with never a real company.
( not you Prophet, to the shills )
Save those investors
RDAR
No-Quarter No-Quarter 45 minutes ago
Good to know, thx!
LetGoodTimesRoll LetGoodTimesRoll 46 minutes ago
The criminality surrounding BLUE Sheets data is rampant...

https://www.sec.gov/newsroom/press-releases/2025-5?utm_medium=email&utm_source=govdelivery
FOXO
Seminole Red Seminole Red 46 minutes ago
https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/472742874_1004087688423643_1614366062036311373_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=nfcGrMsEIhAQ7kNvgF3nw1U&_nc_zt=23&_nc_ht=scontent-mia3-2.xx&_nc_gid=AZgGdnGS_3zIT8EnJ2PY5KX&oh=00_AYA_PYWQyRmy2OxdvryhKxL8uHQSf69FZtEDZ_CZJ06VFQ&oe=678BF3D
Bubae Bubae 46 minutes ago
New shares flying everywhere from the looks of the filings. Form 144 filed on January 10th by Atlas Merchant Capital LLC intent to sell 1,241,144 shares. approximate date of sale listed as 01/10/2025. Robert E. Diamond, Triller Chairman of the Board, Chief Executive Officer of Atlas Merchant Capita
ILLR
meshcan meshcan 48 minutes ago
Yes, hence I was saying the really numbers will be in a couple quarters from now, August CC will be two full quarters that we have Vyvanse sell numbers.

CC: NASDAC2020
ELTP
PlaneReflection PlaneReflection 49 minutes ago
Remember when you said it won't pass $2 again?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174119656

Please say it won't pass $10 again, $30 again and it'll never be over $200. Thanks.
FNMA
eagle8 eagle8 50 minutes ago
ATLnsider
@ATLnsider
Global future for $NWBO #DCVax dendritic cell vaccine platform could be unlimited if efficacy is proven to be tumor & tissue agnostic for all solid tumor cancers & when combined with checkpoint inhibitors can also effectively treat all blood or liquid cancers. NWBi
NWBO
PROPHET-of-PROFITS PROPHET-of-PROFITS 51 minutes ago
The old CEO of rdar has a new stock already to transfer all of his garbage into. But you watch the bearish comments here Will Never follow Jacob to that new stock where efforts should be made to protect people from making a bad investment. Negative bearish comments and all the effort to create them
RDAR
Pickme2 Pickme2 52 minutes ago
The only proof here is you constantly saying this is the best setup and challenge...yet it keeps going down down from .31 cents to .03 ...now .05  and despite the company saying this S-1 offering filled with the SEC will cause dilution and shareholders will have a hard time selling...you continue to
ATMH

Your Recent History

EU
ONWD
Onward Medical NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads